Greater understanding of the pathways influencing NF-κB activation and the mechanisms by which it governs microglial polarization may pave the way for the development of novel therapeutic strategies for AD and other neuroinflammatory diseases. This evidence concerns the gene NFKB1 and Alzheimer disease.